Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study
Medical Mycology · 02.03.2023 · 61 (3)
DOI: 10.1093/mmy/myad010 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Mycology, online erschienen am 06.03.2023. Verfasst von Aislinn Cook und 47 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neonatal and Paediatric Infection, St. George's University of London, London, UK. Hauptthemen laut MEDLINE: Candidiasis, Invasive, Fluconazole. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, University of Exeter.
Abstract (Originalsprache)
Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have shown a different profile of those neonates affected with NIC and of fluconazole-resistant Candida spp. isolates in low- and middle-income countries (LMICs) compared to high-income countries (HICs). We describe the epidemiology, Candida spp. distribution, treatment, and outcomes of neonates with NIC from LMICs enrolled in a global, prospective, longitudinal, observational cohort study (NeoOBS) of hospitalized infants <60 days postnatal age with sepsis (August 2018–February 2021). A total of 127 neonates from 14 hospitals in 8 countries with Candida spp. isolated from blood culture were included. Median gestational age of affected neonates was 30 weeks (IQR: 28–34), and median birth weight was 1270 gr (interquartile range [IQR]: 990–1692). Only a minority had high-risk criteria, such as being born <28 weeks, 19% (24/127), or birth weight <1000 gr, 27% (34/127). The most common Candida species were C. albicans (n = 45, 35%), C. parapsilosis (n = 38, 30%), and Candida auris (n = 18, 14%). The majority of C. albicans isolates were fluconazole susceptible, whereas 59% of C. parapsilosis isolates were fluconazole-resistant. Amphotericin B was the most common antifungal used [74% (78/105)], followed by fluconazole [22% (23/105)]. Death by day 28 post-enrollment was 22% (28/127). To our knowledge, this is the largest multi-country cohort of NIC in LMICs. Most of the neonates would not have been considered at high risk for NIC in HICs. A substantial proportion of isolates was resistant to first choice fluconazole. Understanding the burden of NIC in LMIC is essential to guide future research and treatment guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Neonatal and Paediatric Infection, St. George's University of London, London, UK.
- MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.
- Department of Neonatology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
- School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
- Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
- Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
ORCID-Profile: Aislinn Cook, Laura Ferreras-Antolin, Daniel Jarovsky
Förderung
- Medical Research Council
- University of Exeter
Zitieren
APA
Cook, A., Ferreras-Antolin, L., Adhisivam, B., Ballot, D., Berkley, J. A., Bernaschi, P., Carvalheiro, C. G., Chaikittisuk, N., Chen, Y., Chibabhai, V., Chitkara, S., Chiurchiu, S., Chorafa, E., Dien, T. M., Dramowski, A., de Matos, S. F., Feng, J., Jarovsky, D., Kaur, R., …, & Sharland, M. (2023). Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study. Medical Mycology, 61(3). https://doi.org/10.1093/mmy/myad010
Vancouver
Cook A, Ferreras-Antolin L, Adhisivam B, Ballot D, Berkley JA, Bernaschi P, et al. Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study. Medical Mycology. 2023;61(3). doi:10.1093/mmy/myad010
BibTeX
@article{Cook2023,
author = {Cook, Aislinn and Ferreras-Antolin, Laura and Adhisivam, Bethou and Ballot, Daynia and Berkley, James A and Bernaschi, Paola and Carvalheiro, Cristina G and Chaikittisuk, Napaporn and Chen, Yunsheng and Chibabhai, Vindana and Chitkara, Shweta and Chiurchiu, Sara and Chorafa, Elisavet and Dien, Tran Minh and Dramowski, Angela and de Matos, Samantha Faria and Feng, Jinxing and Jarovsky, Daniel and Kaur, Ravinder and Khamjakkaew, Warunee and Laoyookhong, Premsak and Machanja, Edwin and Mussi-Pinhata, Marisa M and Namiiro, Flavia and Natraj, Gita and Naziat, Hakka and Ngoc, Hoang Thi Bich and Ondongo-Ezhet, Claude and Preedisripipat, Kanchana and Rahman, Hafizur and Riddell, Amy and Roilides, Emmanuel and Russell, Neal and Sastry, Apurba S and Tasimwa, Hannington Baluku and Tongzhen, Ji and Wadula, Jeannette and Wang, Yajuan and Whitelaw, Andrew and Wu, Dan and Yadav, Varsha and Yang, Gao and Stohr, Wolfgang and Bielicki, Julia Anna and Ellis, Sally and Warris, Adilia and Heath, Paul T and Sharland, Michael},
title = {Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study},
journal = {Medical Mycology},
year = {2023},
volume = {61},
number = {3},
doi = {10.1093/mmy/myad010}
}
EUVIMED